Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7 - Identification of a critical aromatic amino acid residue at position 33

被引:39
|
作者
Barre, Lydia
Fournel-Gigleux, Sylvie
Finel, Moshe
Netter, Patrick
Magdalou, Jacques
Ouzzine, Mohamed
机构
[1] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France
[2] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
关键词
site-directed mutagenesis; substrate specificity; UDP-glucuronosyltransferase; UGT2B4; UGT2B7;
D O I
10.1111/j.1742-4658.2007.05670.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human UDP-glucuronosyltransferase (UGT) isoforms UGT2B4 and UGT2B7 play a major role in the detoxification of bile acids, steroids and phenols. These two isoforms present distinct but overlapping substrate specificity, sharing common substrates such as the bile acid hyodeoxycholic acid (HDCA) and catechol-estrogens. Here, we show that in UGT2B4, substitution of phenylalanine 33 by leucine suppressed the activity towards HDCA, and impaired the glucuronidation of several substrates, including 4-hydroxyestrone and 17-epiestriol. On the other hand, the substrate specificity of the mutant UGT2B4F33Y, in which phenylalanine was replaced by tyrosine, as found at position 33 of UGT2B7, was similar to wild-type UGT2B4. In the case of UGT2B7, replacement of tyrosine 33 by leucine strongly reduced the activity towards all the tested substrates, with the exception of 17-epiestriol. In contrast, mutation of tyrosine 33 by phenylalanine exhibited similar or even somewhat higher activities than wild-type UGT2B7. Hence, the results strongly indicated that the presence of an aromatic residue at position 33 is important for the activity and substrate specificity of both UGT2B4 and UGT2B7.
引用
收藏
页码:1256 / 1264
页数:9
相关论文
共 50 条
  • [31] Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population
    Saeki, M
    Saito, Y
    Jinno, H
    Tanaka-Kagawa, T
    Ohno, A
    Ozawa, S
    Ueno, K
    Kamakura, S
    Kamatani, N
    Komamura, K
    Kitakaze, M
    Sawada, J
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (09) : 1048 - 1054
  • [32] Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling
    Uchaipichat, Verawan
    Mackenzie, Peter
    Houston, Brian
    Galetin, Aleksandra
    Miners, John
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
  • [33] Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10
    Kaivosaari, Sanna
    Toivonen, Paivi
    Hesse, Leah M.
    Koskinen, Mikko
    Court, Michael H.
    Finel, Moshe
    MOLECULAR PHARMACOLOGY, 2007, 72 (03) : 761 - 768
  • [34] The glucuronidation of ciclosporine A and tacrolimus is catalyzed by the UDP-glucuronosyltransferase UGT2B7 in human liver and the extrahepatic gastrointestinal tract.
    Strassburg, CP
    Topp, J
    Nguyen, N
    Li, Q
    Ayse, B
    Obermayer-Straub, P
    Tukey, RH
    Manns, MP
    HEPATOLOGY, 1999, 30 (04) : 171A - 171A
  • [35] Enantioselective Inhibition of Carprofen Towards UDP-glucuronosyltransferase (UGT) 2B7
    Fang, Zhong-Ze
    Wang, Haina
    Cao, Yun-Feng
    Sun, Dong-Xue
    Wang, Li-Xuan
    Hong, Mo
    Huang, Ting
    Chen, Jian-Xing
    Zeng, Jia
    CHIRALITY, 2015, 27 (03) : 189 - 193
  • [36] Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity
    You, Byoung Hoon
    Gong, Eun Chae
    Choi, Young Hee
    MOLECULES, 2018, 23 (02):
  • [37] Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
    Kahma, Helina
    Filppula, Anne M.
    Neuvonen, Mikko
    Tarkiainen, E. Katriina
    Tornio, Aleksi
    Holmberg, Mikko T.
    Itkonen, Matti K.
    Finel, Moshe
    Neuvonen, Pertti J.
    Niemi, Mikko
    Backman, Janne T.
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (02) : 141 - 150
  • [38] Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11
    Beaulieu, M
    Lévesque, E
    Hum, DW
    Bélanger, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) : 44 - 50
  • [39] The Human UGT2B7 Nanodisc
    Cook, Ian
    Asenjo, Anna B.
    Sosa, Hernando
    Leyh, Thomas S.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (03) : 198 - 204
  • [40] Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers
    Izukawa, Takeshi
    Nakajima, Miki
    Fujiwara, Ryoichi
    Yamanaka, Hiroyuki
    Fukami, Tatsuki
    Takamiya, Masataka
    Aoki, Yasuhiro
    Ikushiro, Shin-ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1759 - 1768